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Abstract
Background: Laughter Yoga consists of physical exercise, relaxation techniques and simulated vigorous laughter. It
has been associated with physical and psychological benefits for people in diverse clinical and non-clinical settings,
but has not yet been tested in a haemodialysis setting. The study had three aims: 1) to examine the feasibility
of conducting Laughter Yoga for patients with end stage kidney disease in a dialysis setting; 2) to explore the
psychological and physiological impact of Laughter Yoga for these patients; and 3) to estimate the sample size
required for future research.
Methods: Pre/post intervention feasibility study. Eighteen participants were recruited into the study and Laughter
Yoga therapists provided a four week intradialytic program (30-min intervention three times per week). Primary
outcomes were psychological items measured at the first and last Laughter Yoga session, including: quality of life;
subjective wellbeing; mood; optimism; control; self-esteem; depression, anxiety and stress. Secondary outcomes
were: blood pressure, intradialytic hypotensive episodes and lung function (forced expiratory volume). Dialysis
nurses exposed to the intervention completed a Laughter Yoga attitudes and perceptions survey (n = 11). Data were
analysed using IBM SPSS Statistics v22, including descriptive and inferential statistics, and sample size estimates were
calculated using G*Power.
Results: One participant withdrew from the study for medical reasons that were unrelated to the study during
the first week (94 % retention rate). There were non-significant increases in happiness, mood, and optimism and
a decrease in stress. Episodes of intradialytic hypotension decreased from 19 pre and 19 during Laughter Yoga to
4 post Laughter Yoga. There was no change in lung function or blood pressure. All nurses agreed or strongly
agreed that Laughter Yoga had a positive impact on patients’ mood, it was a feasible intervention and they would
recommend Laughter Yoga to their patients. Sample size calculations for future research indicated that a minimum
of 207 participants would be required to provide sufficient power to detect change in key psychological variables.
Conclusions: This study provides evidence that Laughter Yoga is a safe, low-intensity form of intradialytic physical
activity that can be successfully implemented for patients in dialysis settings. Larger studies are required, however,
to determine the effect of Laughter Yoga on key psychological variables.
Trial registration: Australian New Zealand Clinical Trials Registry - ACTRN12614001130651. Registered 23 October
2014.
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Background
Laughter can provide a positive respite from the adverse
emotional effects associated with illness [1] by improving
mood [2–4], reducing depression [4–7], and improving
life satisfaction [7] and quality of life [4]. These effects
have been shown whether laughter has been spontan-
eous or simulated [7, 8]. Laughter Yoga (LY), developed
in India in 1995, is a combination of simulated laughter
with Yoga breathing exercises that is typically conducted
in a group setting. It incorporates clapping, arm and leg
movement, deep breathing exercises, gentle neck and
shoulder stretches as well as facilitated laugh and smile
exercises [9, 10]. It can improve life satisfaction, subject-
ive wellbeing, and mood, and reduce anxiety and stress
in healthy participants [11].
Despite the many psychological benefits of laughter it
is unclear if these benefits translate into a positive inter-
vention for people with end stage kidney disease (ESKD)
[12]. Given that Laughter Yoga is both a physical and
psychological therapy, takes only 30 to 45 min, and is
appropriate for group settings [11], it was chosen over
other laughter-based and exercise therapies. Thus, the
study had three aims: 1) to examine the feasibility of
conducting LY for patients with ESKD in a dialysis set-
ting; 2) to explore the psychological and physiological
impact of LY for patients with ESKD receiving haemodi-
alysis treatment; and 3) to estimate the sample size that
would be required to adequately power a future study.
Methods
Design
Pre- and post-intervention feasibility study.
Participants and setting
This feasibility study was conducted in one satellite
haemodialysis centre in Melbourne, Australia. The con-
venience sample was from the sampling frame of one
morning and one afternoon dialysis shift. Justification
for the convenience sample and sample size was based
on the feasibility aims of the study. Participants were
invited to partake in the study if they met the following
inclusion/exclusion criteria: people with ESKD receiving
haemodialysis, 18 years of age and over, not pregnant, able
to understand spoken English, and receiving haemodialy-
sis treatment for greater than three months. People were
excluded if they had been hospitalised in the month prior
to the study commencing.
LY Intervention
The LY intervention was delivered during 11 consecutive
haemodialysis treatments over a four week period during
November and December 2013. Prior to the intervention
the LY therapists met with dialysis patients, dialysis
nurses and the researchers to tailor the LY intervention
to ensure feasibility and safety. The intervention was deliv-
ered by two trained and experienced LY therapists with
each session taking approximately 30 to 45 min, conducted
within the first two hours of haemodialysis treatment.
The intervention consisted firstly of 10 minutes of
breathing and stretching exercises: deep belly breathing;
body stretching, arms and legs; gentle neck and shoulder
stretches, turning the head to the right and left; and smil-
ing to loosen up face muscles; and a throat/chest/belly
laugh exercise. The second ten minute section consisted
of facilitated laughter exercises, in conjunction with chant-
ing ho, ho, ho, ha, ha, ha, and (non-dialysis arm) clapping
or slapping of the thigh. Laughs were facilitated in this
order: greeting laugh; handshaking with therapists, and
waving to others; Mexican wave; aloha laugh; triathlon
laugh, winding up the dialysis machine to make it go faster
laugh; clock watching laugh; run out of the ward laugh;
shower laugh; brushing teeth laugh; cup of tea laugh. The
final 10 min consisted of Laughter Meditation including
body relaxing; smiling and relaxing; giggle; freestyle
laughter exercises; breathing and relaxing and ending with
application of ‘laughter lotion’.
Measures
Psychological variables
Participants were invited to complete a questionnaire
prior to the first LY session (T1) and after the last LY ses-
sion (T2). The questionnaire included measures of general
life satisfaction, subjective wellbeing, mood, optimism,
control, self-esteem, depression, stress and anxiety. These
measures were chosen because they are theoretically
consistent with psychological wellbeing and have recently
been explored with a non-clinical sample that undertook a
laughter yoga intervention [11]. Furthermore, quality of life
tools such as the KDQOL are largely symptom-focused
and would not be expected to improve with a LY interven-
tion in a feasibility study.
a) General Life Satisfaction (GLS) was measured using
a single item, “How satisfied are you with your
life as a whole?” Participants responded on a 0–10
scale, anchored by 0 = “not at all satisfied” to
10 = “completely satisfied”.
b) Subjective Wellbeing (SWB) was measured using
the Personal Wellbeing Index (PWI) [13]. This is a
7-item index to assess satisfaction with the domains
of life that contribute to general life satisfaction.
The domains of life are standard of living, health,
achievements, personal relationships, safety,
community, and future security. An optional eighth
life domain, spirituality or religion, was included
for this study. Participants rated their level of
satisfaction with each domain on a 0–10 scale as
described for GLS.
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c) Mood was measured using nine affective descriptors
specifically selected to represent the four quadrants
of Russell’s circumplex model of affect [14].
Participants responded according to how each of the
following described their feelings when they think
about their life in general on a 0–10 scale, anchored
by 0 = “not at all” to 10 = “extremely”. The affective
terms were happy, content, tired, active, miserable,
alert, enthusiastic, sad, and distressed. Responses to
the items ‘happy’, ‘content’ and ‘alert’ were averaged
to compute a total score for Homeostatically
Protected Mood (HP Mood) [15], reflecting the type
of general positive mood that dominates evaluations
of subjective wellbeing.
d) Optimism was measured using the three optimism
items from the Life Orientation Test-Revised
(LOT-R) [16]. Participants rated the extent to
which they agreed with each item on a 0–10 scale,
anchored by 0 = “do not agree at all” and 10 =
“completely agree”.
e) Control was measured using five items from Pearlin
and Schooler’s Mastery scale [17]. Participants
rated the extent to which each statement applied
to them in general on a scale from 0 = “not at all”
to 10 = “extremely”.
f ) Self Esteem was measured using the five positively
worded items from Rosenberg’s Self-Esteem Scale
[18]. Participants rated their level of agreement with
each item as for the Optimism scale described above.
g) Depression, Stress, and Anxiety (i.e., negative
emotional states) were measured using the subscales
of the DASS-21 [19]. Participants rated the extent
to which each statement applied to them over the
past week on a scale from 0 = “not at all” to 10 =
“extremely”. Though the first subscale is termed
‘depression’ and will be referred to herein as such,
the DASS is not a diagnostic tool and this indicator
best represents depressed mood.
Lung function
Lung function was measured by the Medical Research
Council (MRC) dyspnoea scale, forced vital capacity
(FVC), and forced expiratory volume in 1 second (FEV1).
FEV1% was calculated based on FVC and FEV1 data. Data
were collected at five time points. At both the first and the
last LY sessions (T1 and T2), lung function was measured
twice, including immediately pre- and post-intervention
(i.e., T1 pre LY, T1 post LY, T2 pre LY, and T2 post LY). To
explore if there were any longer term effects of LY, lung
function was measured again one month after the LY inter-
vention ceased which we termed Time Point 3 (T3). Data
were collected for 17 patients at the first LY session (T1),
14 patients on the last LY session (T2), and 12 patients one
month post-intervention (T3).
Blood pressure
Mean arterial pressure (MAP) was calculated as systolic
blood pressure + 2 × diastolic blood pressure divided by
3 [20]. Post haemodialysis mean arterial pressure mea-
sures were collated retrospectively for all participants at
11 haemodialysis treatments prior to (pre) and 11 haemo-
dialysis treatments during (post) LY intervention within
15 min following the completion of each haemodialysis
treatment. Data from the 11 data points were combined to
produce a mean pre- and post-MAP for each participant.
Intradialytic hypotension (IDH) episodes
The European Best Practice Guidelines definition of intra-
dialytic hypotension, a decrease in blood pressure associ-
ated with symptoms requiring an intervention an additional
intervention was used to define IDH episodes [21]. The
number of IDH episodes recorded for participants in the
four weeks prior to the LY intervention (pre), four weeks of
the LY intervention (during), and four weeks after the LY
intervention (post) was compiled retrospectively.
Nursing staff perceptions of LY
Nursing staff in the haemodialysis unit were invited to
complete an anonymous 12-item web-based question-
naire to explore their perceptions of the intervention.
The author-devised questionnaire contained four demo-
graphic questions, five quantitative evaluation items and
three open-ended items that allowed participants to pro-
vide more in-depth feedback and comments about the
intervention.
Data analysis
Quantitative data were analysed using IBM SPSS Statistics
version 22 (IBM Corp, Armonk, NY, USA), including de-
scriptive and inferential statistics. Correlations were used
to explore relationships between age and FEV1% and BMI
and FEV1%. For parametric data, comparison of pre- and
post-intervention data with two time points (i.e., same day
FEV1%, MAP) were analysed using paired samples t-tests
and those with three time points (i.e., T1 – T3 FEV1%)
were analysed using repeated measures analysis of vari-
ance (ANOVA). For nonparametric data (i.e., psycho-
logical variables), the Wilcoxon Signed Rank Test was
used to compare pre- and post-intervention responses.
Chi square analysis, including an odds ratio and confi-
dence interval, was used to compare pre- and post-
intervention IDH data. Sample size calculations were
conducted using G-Power version 3.1, using an alpha
value of .05 and power of 80 %. Three psychological var-
iables that were considered most amenable to change
following an intervention such as LY (i.e., associated
with relaxation and positive mood) were depression,
anxiety and stress, all measured using the DASS [19].
These variables represent more transient, temporary
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states, that are more susceptible to change by interven-
tion, compared to other psychological variables such as
self-esteem and subjective wellbeing which are inher-
ently stable over time [22, 23].
Ethical considerations
This feasibility study was approved by both the Monash
Health Human Research Ethics Committee B and the
Deakin University Human Research Ethics Committee.
All aspects of the research were conducted in accord-
ance with the Declaration of Helsinki and its revisions
as well as the National Health and Medical Research
Council guidelines of Australia.
Results
Eighteen patients consented to participate in the study,
and 17 participants continued with the intervention for
the duration of the study (94 % retention). One 56 year
old male withdrew from the study during the first week
due to a hospital admission that was unrelated to the
study. Thus the final sample included 10 males (58.8 %)
and 7 females (41.2 %), who ranged in age from 20–89
years (Mean = 68.06, SD = 17.23) and had a mean body
mass index of 24.09 (SD = 5.04, Range = 17.4–37.1).
Psychological variables
Thirteen out of 17 participants completed the T1 ques-
tionnaire (seven males and six females), 8 subsequently
completed the T2 questionnaire (five males and three
females). One additional participant completed the T2
evaluation though he had not completed the T1 question-
naire. The major reason for these low survey response
rates was the researcher’s decision not to further burden
the participants who already have a significant chronic
disease burden. Table 1 presents the mean scores on all
measured variables for participants who completed both
the T1 and T2 questionnaires.
Subtle increases were observed for GLS, HPMood,
Optimism, and Control, and subtle decreases were also
reported for Stress. Both Anxiety and Depression were
slightly increased at T2 compared to T1. There was a very
minor increase in SWB from T1 to T2. None of these
differences were statistically significant.
Lung function
There was no change in MRC dyspnoea scale scores
with identical scores obtained for all patients at T1, T2,
and T3. Individual scores ranged from 1 to 4, and the
mean score on all occasions was 1.80 (SD = 1.03). The
pattern of scores pre and post LY at T1 and T2 sug-
gested that individuals responded differently to the inter-
vention. For example, one person had a FEV1% that
increased by 18 points (Pre = 50, Post = 68) between the
pre and post intervention data collection at T1, while
another participant had a decrease of 18 points (Pre = 95,
Post = 77). At T1 (n = 17), eight participants recorded a
higher FEV1% after LY, eight participants recorded a lower
FEV1%, and one participant remained the same pre and
post LY. The mean change in FEV1% at T1 was −0.06. At
T2 (n = 14), six participants recorded a higher FEV1%
after LY, seven participants recorded a lower FEV1%, and
one participant remained the same. The mean change in
FEV1% at T2 was −2.14. There was no correlation be-
tween age and lung function or BMI and lung function at
any of the five time points. A mean score was calculated
for each of the five data collection points (Table 2). There
was no immediate effect of the LY on lung function, based
on a comparison of pre and post LY mean scores at T1
(i.e., same day FEV1%).
Mean arterial pressure (MAP)
Post haemodialysis MAP data was recorded for all par-
ticipants (n = 17) at 11 haemodialysis treatments prior to
(pre) and 11 haemodialysis treatments during (post) the
LY intervention. Data from the 11 data points were
combined to produce a mean pre and post MAP for
each participant. Results were mixed with ten patients
exhibiting a decrease in their mean MAP between pre
and post phases and seven exhibiting an increase. Pre
(M = 87.85, SD = 11.72, Range = 72.76 – 115.67) and post
(M = 86.25, SD = 8.90, Range = 73.42 – 106.27) MAP
data were compared but did not differ significantly,
t (16) = 1.14, p = 0.27, η2 = 0.07. The mean decrease in
Table 1 Comparisons of scores on all measured variables from
T1 to T2 (n = 8)
Time 1 Time 2
Variable Mean SD Mean SD Wilcoxon Z test
GLS 71.25 21.67 75.00 17.73 Z = −.816, p > 0.05
SWB 77.68 12.00 78.57 8.27 Z = −.341, p > 0.05
HPMood 66.88 24.57 69.58 20.66 Z = −.954, p > 0.05
Optimism 59.79 27.41 62.50 21.21 Z = −.170, p > 0.05
Control 40.29 18.67 44.29 20.05 Z = −.944, p > 0.05
Self Esteem 75.00 17.79 74.75 12.87 Z = −.070, p > 0.05
Depressed mood 31.79 20.46 34.11 17.60 Z = −.284, p > 0.05
Anxiety 27.14 15.80 33.04 13.86 Z = −1.185, p > 0.05
Stress 35.36 21.35 31.07 20.51 Z = −.211, p > 0.05
Table 2 FEV1% scores across the five data points
Time n Mean SD Minimum Maximum t df p
T1 pre LY 17 63.35 18.03 40 99 0.03 16 0.98
T1 post LY 17 63.29 17.11 29 93
T2 pre LY 14 64.21 16.87 46 102 0.91 13 0.38
T2 post LY 14 62.07 16.16 43 95
T3 12 55.17 14.22 26 73
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MAP was 1.60 with a 95 % confidence interval ranging
from −1.38 to 4.58.
Intradialytic hypotensive (IDH) episodes
There were 19 IDH episodes recorded in the month pre-
ceding the LY, 19 IDH episodes recorded during, and four
recorded post LY intervention. Based on these data, the
odds of IDH decreased by 80 % (OR = 0.20, CI = 0.07 –
.61) which was statistically significant (χ21 = 9.76, p = .002).
The reasons for this difference are unclear but it is
unlikely that a change of this magnitude would be related
to the intervention alone.
Nursing staff perceptions of LY
Eleven Registered Nurses from the dialysis clinic com-
pleted the online questionnaire (61 % response rate)
(Table 3). Only one participant had any prior experience
with LY and all participants had worked a shift in the
unit while the LY study was running. The majority of
respondents (82 %) either agreed or strongly agreed that
LY had a positive impact on their patients’ mood and
that they would recommend LY to future patients. Over-
all, 9 participants (82 %) were Satisfied or Very satisfied
with the LY intervention during dialysis; the remaining
two participants selected Neutral.
Sample size calculation for future study
Sample sizes were calculated based on the three key psy-
chological variables considered most amenable to change,
as follows: Anxiety, n = 28; Stress, n = 74; and Depression,
n = 207.
Discussion
This study demonstrated the feasibility of conducting LY
for patients with ESKD in dialysis settings. Despite par-
ticipant attrition in some components of the evaluation
(e.g., lung function, participant survey), the intervention
itself recorded a 94 % retention rate over four weeks
which indicated that LY was an acceptable intervention
for patients. The only withdrawal from the study was a
patient who was admitted to hospital for reasons unre-
lated to the intervention.
Participants reported slight increases in happiness,
mood and optimism and had subtle decreases in stress,
consistent with LY research in the other populations
[24]. For example, feelings of stress were substantially
decreased for diabetic patients after participating in LY
[24] and feelings of liveliness, activation, cheerfulness, and
friendliness increased for patients awaiting organ trans-
plantation [25]. Similarly, our study had a positive impact
on wellbeing in terms of improved enthusiasm, positive
attitude, ability to laugh for no reason, optimism, stress
level, and physical and mental relaxation.
Sample size calculations conducted as part of this
study identified that a sample as small as 28 participants
may be sufficient to detect a significant change in
anxiety, but at least 200 participants would be advisable
to detect changes in other key variables. Importantly,
although there was minimal attrition from the interven-
tion itself, only 76 % of participants completed the
pre-intervention survey and 53 % completed the post-
intervention survey; 47 % completed both surveys. This
should be taken into account when determining sample
size.
We found no significant change in the overall mean
post dialysis MAP scores associated with the LY interven-
tion. A randomised controlled trial of a LY intervention
for healthy IT professionals found that blood pressure and
cortisol level were significantly lower in the intervention
group compared with a control group [26] which con-
trasts with our findings. Furthermore, we found no differ-
ences in episodes of IDH during the LY when compared
to the previous month’s data. The finding that IDH epi-
sodes decreased by 80 % in the month following the LY
intervention remains unexplained and although postula-
tion can occur we have no reason to believe that this
was associated with LY. One consideration that may be
explored is that LY involves the potentially increasing
blood pressure effect of exercise with the potentially
soothing, blood pressure lowering effect of meditation
resulting in no change.
Humour is observed frequently in haemodialysis units
[27] so it was not surprising that nursing staff in the
haemodialysis unit were supportive of the LY. The
support and involvement of nursing staff in the haemo-
dialysis unit is pivotal to the success of such an interven-
tion and was clearly evident in this study, with nurses’
spontaneously participating in each LY session. Nurses’
engagement is particularly important in terms of the
long term sustainability of an intervention such as LY.
Table 3 Nursing staff responses regarding LY in their haemodialysis unit
Item Strongly agree Agree Neutral Disagree Strongly disagree
Laughter Yoga had a positive impact on the mood of patients 5 (45 %) 4 (36 %) 2 (18 %) 0 0
I would recommend Laughter Yoga to my patients 5 (45 %) 4 (36 %) 2 (18 %) 0 0
I would like to have more information about Laughter Yoga 1 (9 %) 5 (45 %) 5 (45 %) 0 0
I had concerns regarding the safety of Laughter Yoga during dialysisa 0 1 (9 %) 3 (27 %) 4 (36 %) 2 (18 %)
aOne participant selected ‘Not applicable’ for this item
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Although there was no improvement in lung function
in this study there was also no significant reduction in
lung function. This is particularly pertinent given the
mixed findings about the impact of laughter therapies
on respiratory function of patients on dialysis, many who
suffer pulmonary compromise [28]. One study of patients
with severe COPD indicated that humour-induced smiling
is beneficial but laughter may be detrimental to patients
[29]. Our study did not demonstrate a negative impact on
respiratory function.
For patients with ESKD a strong sense of humour has
been shown to assist in coping with stressful life events,
increasing the likelihood of survival into old age [25].
Adding LY physical exercise may implicate LY as a sus-
tainable laughter-based exercise intervention. This is im-
portant because sustainability of any intradialytic physical
activity has been rarely successful in the ESKD group [30].
The addition of the meditational relaxation component of
LY may also be responsible for the subtle increases in hap-
piness, mood and optimism and the subtle decreases in
stress. This meditation component may be particularly
useful to reduce any increased anxiety related to the dialy-
sis procedure [31].
Limitations
Although the sample was small, the 17 participants pro-
vided valuable data for analysis and insights into the
feasibility of such an intervention for patients in one
haemodialysis setting. Further studies with larger sam-
ples, and the inclusion of a control group, may provide
better results in examining the effects of LY for haemo-
dialysis patients in more diverse settings.
Conclusion
Evidence to support positive health-related effects of
LY is still limited, although this study suggests LY
may be a beneficial therapeutic intervention for
haemodialysis patients. This study has demonstrated
that LY is a safe, inexpensive, accessible and low-
intensity form of physical activity which has the po-
tential to improve mood and decrease the anxiety of
patients with ESKD in haemodialysis settings. The
findings suggest the need for further research in this
field with larger samples and controlled designs that
may provide a greater understanding of the thera-
peutic benefits of LY.
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